Key facts
- It has raised $7.3M; the latest was Early Stage VC in Dec 2025.
- Notable investors include MedTech Innovator, Foothill Ventures, AIX Ventures, Page One Ventures, LDV Partners — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Ryght AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Ryght AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ryght AI
Developer of an enterprise-scale platform designed to utilize generative artificial intelligence for real-time biopharma discovery. The company's platform fine-tunes large language models designed for real-time data with verified and secure customer data stores tailored to life sciences companies' needs, enabling pharma companies to empower discovery, clinical, and commercial teams with unprecedented, actionable knowledge.
- Sector
- Healthcare
- HQ
- Anaheim, CA, United States
- Founded
- 2023
- Employees
- 22
- Website
- ryght.ai/
- Ownership
- Privately Held (backing)
Ryght AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ryght AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ryght AI in its N-PORT filings yet. We sweep new filings monthly.